StockData
OptimizeRx Corp logo

OptimizeRx Corp (OPRX) stock

OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3030% below fair value
$6.94+0.30 (+4.52%)

Close on Nov 17, 2026Market cap $130.72MP/E 28.9Yield –

OptimizeRx price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

OptimizeRx's price to sales ratio was 1.7× on Nov 11, 2026, against 2.6× a year earlier. Over the last 5 years it ranged from 0.9× to 19.2×, with a median of 2.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.7×−0.4
2025Dec 31, 20252.1×+1.1
2024Dec 31, 20241.0×−3.2
2023Dec 29, 20234.2×−0.6
2022Dec 30, 20224.8×−14.4
2021Dec 31, 202119.2×+0.1
2020Dec 31, 202019.1×+13.1
2019Dec 31, 20196.0×−1.1
2018Dec 31, 20187.0×+2.6
2017Dec 29, 20174.4×+1.2
2016Dec 30, 20163.2×−1.7
2015Dec 31, 20154.9×+0.5
2014Dec 31, 20144.4×−6.7
2013Dec 31, 201311.1×–

More OptimizeRx figures

See a number that looks wrong?